 |
|
Pharmacological Treatment of Alcohol Dependence
A Review of the Evidence
James C. Garbutt, MD;
Suzanne L. West, PhD, MPH;
Timothy S. Carey, MD, MPH;
Kathleen N. Lohr, PhD;
Fulton T. Crews, PhD
JAMA. 1999;281:1318-1325.
Context Alcoholism affects approximately 10% of Americans at some time in their lives. Treatment consists of psychosocial interventions, pharmacological interventions, or both, but which drugs are most effective at enhancing abstinence and preventing relapse has not been systematically reviewed.
Objective To evaluate the efficacy of 5 categories of drugs used to treat alcohol dependence—disulfiram, the opioid antagonists naltrexone and nalmefene, acamprosate, various serotonergic agents (including selective serotonergic reuptake inhibitors), and lithium.
Data Sources Reports of randomized controlled trials, nonrandomized trials, and other study designs in English, French, and German identified from multiple searches of MEDLINE, EMBASE, and specialized databases; hand searching bibliographies of review articles; searches for unpublished literature; and discussions with investigators in the field.
Study Selection We included all studies on alcohol-dependent human subjects aged 18 years or older from all inpatient and outpatient settings between 1966 and December 1997 that met our inclusion criteria.
Data Extraction We abstracted the following information: study design and blinding, diagnostic instrument and severity assessment, drug interventions and cointerventions, demographic and comorbidity details about patients, compliance, and numerous outcome measures (eg, relapse, return to drinking, drinking or nondrinking days, time to first drink, alcohol consumed per unit of time, craving). We graded quality of the individual articles (scale, 0-100) independently from the strength of evidence for each drug class (A, strong and consistent evidence of efficacy in studies of large size and/or high quality; B, mixed evidence of efficacy; C, evidence of lack of efficacy; and I, insufficient evidence).
Data Synthesis Of 375 articles evaluated, we abstracted and analyzed data from 41 studies and 11 follow-up or subgroup studies. Naltrexone (grade A) reduces the risk of relapse to heavy drinking and the frequency of drinking compared with placebo but does not substantially enhance abstinence, ie, avoidance of any alcohol consumption. Acamprosate (grade A, from large-scale studies in Europe) reduces drinking frequency, although its effects on enhancing abstinence or reducing time to first drink are less clear. Controlled studies of disulfiram (grade B) reveal a mixed outcome pattern—some evidence that drinking frequency is reduced but minimal evidence to support improved continuous abstinence rates. The limited data on serotonergic agents were not very promising (grade I), although most studies were confounded by high rates of comorbid mood disorders. Lithium lacks efficacy (grade C) in the treatment of primary alcohol dependence.
Conclusions Recent reports documenting that naltrexone and acamprosate are more effective than placebo in the treatment of alcoholism justify clinical interest in use of these medications for alcohol-dependent patients. Use of disulfiram is widespread but less clearly supported by the clinical trial evidence; however, targeted studies on supervised administration of disulfiram may be warranted. Use of existing serotonergic agents or lithium for patients with primary alcohol dependence does not appear to be supported by the efficacy data available at this time; these medications may still have a positive effect in patients with coexisting psychiatric disorders.
Author Affiliations: Departments of Psychiatry (Drs Garbutt and Crews), Medicine (Dr Carey), and Pharmacology (Dr Crews) and Bowles Center for Alcohol Studies (Drs Garbutt and Crews), School of Medicine, and the School of Public Health (Drs West and Lohr), University of North Carolina at Chapel Hill; and Research Triangle Institute, Research Triangle Park, NC (Drs West and Lohr).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
April 14, 1999
JAMA. ;281():1347-1348.
FULL TEXT
Do you have a drinking problem?
JAMA. ;281():1352-1352.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Alcohol abuse and pulmonary disease
Boe et al.
J. Leukoc. Biol. 2009;86:1097-1104.
ABSTRACT
| FULL TEXT
Best Practices: Comparing Medication Treatments in Mental Health: Drug Class Reviews and Policy Challenges
Carey et al.
Psychiatr. Serv. 2007;58:746-748.
ABSTRACT
| FULL TEXT
Emerging approaches to managing alcohol dependence
SWIFT
Am J Health Syst Pharm 2007;64:S12-S22.
ABSTRACT
| FULL TEXT
Brief Interventions for Problem Drinking: Another Piece of the Puzzle
O'Connor
ANN INTERN MED 2007;146:223-225.
FULL TEXT
Alcohol Use and Anxiety: Diagnostic and Management Issues
Brady et al.
Am. J. Psychiatry 2007;164:217-221.
FULL TEXT
THE EFFECTIVENESS OF A TAILORED INTERVENTION FOR EXCESSIVE ALCOHOL CONSUMPTION PRIOR TO ELECTIVE SURGERY
SHOURIE et al.
Alcohol Alcohol 2006;41:643-649.
ABSTRACT
| FULL TEXT
Psychotic Spectrum Disorders and Alcohol Abuse: A Review of Pharmacotherapeutic Strategies and a Report on the Effectiveness of Naltrexone and Disulfiram
Petrakis et al.
Schizophr Bull 2006;32:644-654.
ABSTRACT
| FULL TEXT
Pharmacologic Control of Ventricular Rate: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery
Martinez et al.
Chest 2005;128:56S-60S.
ABSTRACT
| FULL TEXT
EFFECT OF COMMUNITY NURSE FOLLOW-UP WHEN TREATING ALCOHOL DEPENDENCE WITH ACAMPROSATE
PELC et al.
Alcohol Alcohol 2005;40:302-307.
ABSTRACT
| FULL TEXT
Unhealthy Alcohol Use
Saitz
NEJM 2005;352:596-607.
FULL TEXT
Treatment for alcohol related problems
Ritson
BMJ 2005;330:139-141.
FULL TEXT
A PRAGMATIC TRIAL OF ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE IN PRIMARY CARE
KIRITZE-TOPOR et al.
Alcohol Alcohol 2004;39:520-527.
ABSTRACT
| FULL TEXT
Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology
Lingford-Hughes et al.
J Psychopharmacol 2004;18:293-335.
A COMPARISON OF TWO INTENSITIES OF PSYCHOSOCIAL INTERVENTION FOR ALCOHOL DEPENDENT PATIENTS TREATED WITH ACAMPROSATE
Hammarberg et al.
Alcohol Alcohol 2004;39:251-255.
ABSTRACT
| FULL TEXT
Does Acamprosate Improve Reduction of Drinking As Well As Aiding Abstinence?
Chick et al.
J Psychopharmacol 2003;17:397-402.
ABSTRACT
Inhibition of Invasion and Angiogenesis by Zinc-Chelating Agent Disulfiram
Shian et al.
Mol. Pharmacol. 2003;64:1076-1084.
ABSTRACT
| FULL TEXT
Acamprosate for the Adjunctive Treatment of Alcohol Dependence
Overman et al.
The Annals of Pharmacotherapy 2003;37:1090-1099.
ABSTRACT
| FULL TEXT
BACLOFEN EFFICACY IN REDUCING ALCOHOL CRAVING AND INTAKE: A PRELIMINARY DOUBLE-BLIND RANDOMIZED CONTROLLED STUDY
Addolorato et al.
Alcohol Alcohol 2002;37:504-508.
ABSTRACT
| FULL TEXT
DOES PSYCHOSOCIAL TREATMENT ENHANCE THE EFFICACY OF ACAMPROSATE IN PATIENTS WITH ALCOHOL PROBLEMS?
de Wildt et al.
Alcohol Alcohol 2002;37:375-382.
ABSTRACT
| FULL TEXT
Naltrexone in the Treatment of Alcohol Dependence
Krystal et al.
NEJM 2001;345:1734-1739.
ABSTRACT
| FULL TEXT
Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study
Wiesbeck et al.
Alcohol Alcohol 2001;36:329-334.
ABSTRACT
| FULL TEXT
Update in Addiction Medicine
Schneider et al.
ANN INTERN MED 2001;134:387-395.
FULL TEXT
Outpatient Management of Patients with Alcohol Problems
Fiellin et al.
ANN INTERN MED 2000;133:815-827.
ABSTRACT
| FULL TEXT
PHARMACOTHERAPY OF ALCOHOLISM: GAPS IN KNOWLEDGE AND OPPORTUNITIES FOR RESEARCH
Kranzler
Alcohol Alcohol 2000;35:537-547.
ABSTRACT
| FULL TEXT
Managing the heavy drinker in primary care
DTB 2000;38:60-64.
ABSTRACT
| FULL TEXT
Alcoholic liver disease
Walsh and Alexander
Postgrad. Med. J. 2000;76:280-286.
ABSTRACT
| FULL TEXT
Review: studies with sufficient follow-up do not show a clear benefit for pharmacotherapy in alcohol dependence
Mayo-Smith
Evid. Based Med. 2000;5:23-23.
FULL TEXT
Pharmacologic Treatment of Alcohol Dependence
JWatch Psychiatry 1999;1999:9-9.
FULL TEXT
|
